| 241/425 | US=23-A / Câncer Benlloch S, Galbis-Caravajal JM, Massutí B. Differentiation between malignant and benign pleural effusions: methylation specific polymerase chain reaction analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 337-47. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; DERRAME PLEURAL MALIGNO; DERRAME PLEURAL BENIGNO; METILACAO; POLIMERASE; REACAO EM CADEIA |
| 242/425 | US=23-A / Câncer Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR |
| 243/425 | US=23-A / Câncer Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA |
| 244/425 | US=23-A / Câncer Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE |
| 245/425 | US=23-A / Câncer Hayat MA. Prostate carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 391-6. ISBN 978-1-4020-8441-62. |
| 246/425 | US=23-A / Câncer Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE |
| 247/425 | US=23-A / Câncer Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA |
| 248/425 | US=23-A / Câncer Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62. |
| 249/425 | US=23-A / Câncer Dakubo GD, Parr RL, Jakupciak JP. Prostate cancer: detection and monitoring using mitochondrial mutations as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 441-64. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CANCER DE PROSTATA. DIAGNOSTICO; MUTACAO MITOCONDRIAL; BIOMARCADOR; GENETICA MITOCONDRIAL; BIOENERGETICA MITOCONDRIAL; ONCOLOGIA; METABOLISMO CELULAR; MUTACAO DE DNA |
| 250/425 | US=23-A / Câncer El-Sharkawy SL, Abbas NF, El-Hefnawy NG. Prognostic markers in prostatic carcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 465-79. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; MARCADORES PROGNOSTICOS; CARCINOMA DA PROSTATA |
| 251/425 | US=23-A / Câncer Schwarzenbach H, Pantel K. Prostate cancer: detection of free tumor-specific DNA in blood and bone marrow. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 481-97. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; DNA; SANGUE; MEDULA OSSEA; GENETICA; EPIGENETICA; CELULAS DE ACIDOS NUCLEICOS; PLASMA; ANALISE DE MICROSSATELITES; POLIMORFISMOS DE UM UNICO NUCLEOTIDEO; PCR BASEADA FLUORESCENCIA |
| 252/425 | US=23-A / Câncer Turgut AT, Dogra VS. Prostate carcinoma: evaluation using transrectal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 499-520. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CARCINOMA DA PROSTATA; ULTRA-SONOGRAFIA TRANSRETAL; DOPPLER COLORIDO; ULTRA-SONOGRAFIA COM CONTRASTE; ELASTOGRAFIA |
| 253/425 | US=23-A / Câncer Zanzonico P. Prostate cancer: 16B-[18F] Fluoro-5x-Dihydrotesterone (FDHT) whole-body positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 521-30. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; 16B-[18F] FLUORO-5X-DIHYDROTESTERONE (FDHT); TOMOGRAFIA POR EMISSAO DE POSITRONS; RECEPTOR DE ANDROGENO |
| 254/425 | US=23-A / Câncer Nesslinger NJ, Pai HH, Ludgate CM, Nelson BH. Effects of standard treatments on the immune response to prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 531-55. ISBN 978-1-4020-8441-62. |
| 255/425 | US=23-A / Câncer Kalakish S, Torti FM. Vinorelbine, Doxorubicin, and Prednisone in hormone refractory prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 557-64. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; VINORELBINA; DOXORUBICINA; PREDNISONA |
| 256/425 | US=23-A / Câncer Crook J. Locally advanced protate cancer biochemical recurrence after radiotherapy: use of cyclic androgen withdrawal therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 565-77. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; RECORRENCIA LOCALMENTE AVANCADO; BIOQUIMICA; RADIOTERAPIA; TERAPIA CICLICA; ANDROGENO |
| 257/425 | US=29 / Imagem Scher B, Sietz M, Albinger W, Reiser M, Schlenker B, Stief C, Mueller-Lisse U, Dresel S. Value of PET and PET/CT in the diagnostics of prostate and penile cancer. In: Dresel S, editor. Pet in oncology. New York: Springer- Verlag, 2008. p. 159-79. ISBN 978-3-540-31202-4. PET. CANCER DE PROSTATA; PET/CT. CANCER DE PROSTATA; PET. PENIS; PET/CT. ENIS; CANCER DE PROSTATA; ESTADIAMENTO DO CANCER DE PENIS |
| 258/425 | US=30-A / Câncer Venkatesh R, Lomberdi DP. Genitourinary cancer: prostate. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 226-37. ISBN 978-1-5889-0323-0. |
| 259/425 | US=27 / Imagem Valicenti RK, Lin A. Prostate cancer: overview and treatment guidelines for image-guided radiation therapy. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 1-8. ISBN 978-1-420-06078-2. CANCER DE PROSTATA; TRATAMENTO; RADIOTERAPIA GUIADA POR IMAGEM; ESCALONAMENTO DE DOSE |
| 260/425 | US=27 / Imagem Speight JL, Westphalen AC, Coakley FV. The use of imaging modalities in the evaluation and treatment of prostate cancer. In: Valicenti RK, Dicker AP, Jaffray DA. Image-guided radiation therapy of prostate cancer. New York: Informa Helthcare, 2008. p. 9-25. ISBN 978-1-420-06078-2. CANCER DE PROSTATA; TRATAMENTO; METODOS DE IMAGEM; MODELOS DE ESTRATIFICACAO; IMAGEM ANATOMICA; RADIOTERAPIA; IMAGEM FUNCIONAL |